CD44 knockdown using CD44 shRNA in pancreatic ductal adenocarcinoma cells not only efficiently reduced the expression of Zeb1 and Snail1 but also significantly impaired cell proliferation and invasion [89]. This evidence concerns the gene ZEB1 and pancreatic ductal adenocarcinoma.